Comparison of alendronate and raloxifene for treatment of postmenopausal osteoporosis: Results from EFFECT and EFFECT-international

被引：0
|
作者：
Kagan, R
Sambrook, P
Luckey, M
Geusens, P
de Papp, A
Melton, ME
机构：
[1] Fdn Osteoporosis Res & Educ, Oakland, CA USA
[2] Univ Sydney, Sydney, NSW 2006, Australia
[3] St Barnabas Osteoporosis & Metab Bone Dis Ctr, Livingston, NJ 07039 USA
[4] Maastricht Univ, Maastricht, Netherlands
[5] Merck & Co Inc, Whitehouse Stn, NJ USA
来源：
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2003年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：596 / 596
页数：1
相关论文
共 50 条
  • [21] Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women
    Downs, RW
    Bell, NH
    Ettinger, MP
    Walsh, BW
    Favus, MJ
    Mako, B
    Wang, LX
    Smith, ME
    Gormley, GJ
    Melton, ME
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (05): : 1783 - 1788
  • [22] Comparison of the effects of alendronate, risedronate and calcitonin treatment in postmenopausal osteoporosis
    Yildirim, K
    Gureser, G
    Karatay, S
    Melikoglu, MA
    Ugur, M
    Erdal, A
    Senel, K
    Billen, H
    JOURNAL OF BACK AND MUSCULOSKELETAL REHABILITATION, 2005, 18 (3-4) : 85 - 89
  • [23] Patient compliance with raloxifene (daily), alendronate (daily and weekly) and risedronate (daily) in the treatment of postmenopausal osteoporosis
    Ringe, JD
    Christodoulakos, GE
    Mellström, D
    Singh, SP
    Petto, H
    Wagemaker, B
    Nickelsen, T
    Marin, F
    Pavo, I
    BONE, 2005, 36 : S438 - S439
  • [24] Comparison of the effect of raloxifene on bone between Japanese and Caucasian postmenopausal women with osteoporosis.
    Nakamura, T
    Matsumoto, T
    Fukunaga, M
    Watts, S
    Harper, KD
    Uesaka, H
    Tsujimoto, M
    Hamaya, E
    Sato, K
    Tanaka, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S301 - S301
  • [25] Etidronate and alendronate in the treatment of postmenopausal osteoporosis
    Beauchesne, MF
    Miller, PF
    ANNALS OF PHARMACOTHERAPY, 1999, 33 (05) : 587 - 599
  • [26] Effect of raloxifene on cardiovascular adverse events in postmenopausal women with osteoporosis
    Ensrud, K
    Genazzani, AR
    Geiger, MJ
    McNabb, M
    Dowsett, SA
    Cox, DA
    Barrett-Connor, E
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (04): : 520 - 527
  • [27] Effect of raloxifene hydrochloride on postmenopausal Japanese women with osteoporosis.
    Morii, H
    Orimo, H
    Taketani, Y
    Ishii, J
    Inoue, T
    Fujita, T
    Ohashi, Y
    Huster, WJ
    Lakshmanan, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : T588 - T588
  • [28] Effect of raloxifene on clinical fractures in Asian women with postmenopausal osteoporosis
    Nakamura, T
    Liu, J
    Morii, H
    Huang, Q
    Zhu, H
    Qu, Y
    Hamaya, E
    Thiebaud, D
    BONE, 2005, 36 : S430 - S431
  • [29] Effect of raloxifene on clinical fractures in Asian women with postmenopausal osteoporosis
    Nakamura, Toshitaka
    Liu, Jian Li
    Morii, Hirotoshi
    Huang, Qi Ren
    Zhu, Han Min
    Qu, Yongming
    Hamaya, Etsuro
    Thiebaud, Daniel
    JOURNAL OF BONE AND MINERAL METABOLISM, 2006, 24 (05) : 414 - 418
  • [30] Effect of raloxifene on clinical fractures in Asian women with postmenopausal osteoporosis
    Toshitaka Nakamura
    Jian Li Liu
    Hirotoshi Morii
    Qi Ren Huang
    Han Min Zhu
    Yongming Qu
    Etsuro Hamaya
    Daniel Thiebaud
    Journal of Bone and Mineral Metabolism, 2006, 24 : 414 - 418
12345